Objective: To report the North American Fetal Therapy Network (NAFTNet) Registry data on the outcomes of using radiofrequency ablation to treat twin-reversed arterial perfusion (TRAP). Methods: This was a retrospective review of the records of all patients who underwent percutaneous radiofrequency ablation of an acardiac twin after referral to 12 NAFTNet institutions between 1998 and 2008. Maternal, fetal and neonatal data were analyzed. The primary outcome was neonatal survival to 30 days of age. All participating sites conducted this study under institutional review board approval. Results: Of the 98 patients identified, there were no maternal deaths and no women required blood transfusions. Most women (76 of 98; 78%) stayed in the hospital for ≤1 day after the procedure. Mean gestational age at delivery was 33.4 weeks overall and 36.0 weeks for survivors. Median gestational age at delivery was 37.0 weeks. Survival of the pump twin to 30 days was 80% in the overall cohort. Conclusion: The NAFTNet registry data suggest that radiofrequency ablation of the acardiac twin is an effective treatment for TRAP sequence.

Keywords:
Radiofrequency ablation, Twin-reversed arterial perfusion, Monochorionic/diamniotic twin pregnancy, Monochorionic/monoamniotic twin pregnancy
1.
Moore TR, Gale S, Benirschke K: Perinatal outcome of forty-nine pregnancies complicated by acardiac twinning. Am J Obstet Gynecol 1990;163:907-912.
2.
Deprest JA, Audibert F, Van Schoubroeck D, Hecher K, Mahieu-Caputo D: Bipolar coagulation of the umbilical cord in complicated monochorionic twin pregnancy. Am J Obstet Gynecol 2000;182:340-345.
3.
Fries MH, Goldberg JD, Golbus MS: Treatment of acardiac-acephalus twin gestations by hysterotomy and selective delivery. Obstet Gynecol 1992;79:601-604.
4.
Ginsberg NA, Applebaum M, Rabin SA, Caffarelli MA, Kuuspalu M, Daskal JL, Verlinsky Y, Strom CM, Barton JJ: Term birth after midtrimester hysterotomy and selective delivery of an acardiac twin. Am J Obstet Gynecol 1992;167:33-37.
5.
Hamada H, Okane M, Koresawa M, Kubo T, Iwasaki H: Fetal therapy in utero by blockage of the umbilical blood flow of acardiac monster in twin pregnancy (in Japanese). Nippon Sanka Fujinka Gakkai Zasshi 1989;41:1803-1809.
6.
Hecher K, Reinhold U, Gbur K, Hackeloer BJ: Interruption of umbilical blood flow in an acardiac twin by endoscopic laser coagulation (in German). Geburtshilfe Frauenheilkd 1996;56:97-100.
7.
Holmes A, Jauniaux E, Rodeck C: Monopolar thermocoagulation in acardiac twinning. BJOG 2001;108:1000-1002.
8.
Holzgreve W, Tercanli S, Krings W, Schuierer G: A simpler technique for umbilical-cord blockade of an acardiac twin. N Engl J Med 1994;331:56.
9.
McCurdy CM Jr, Childers JM, Seeds JW: Ligation of the umbilical cord of an acardiac-acephalus twin with an endoscopic intrauterine technique. Obstet Gynecol 1993;82(suppl):708-711.
10.
Quintero RA, Romero R, Reich H, Goncalves L, Johnson MP, Carreño C, Evans MI: In utero percutaneous umbilical cord ligation in the management of complicated monochorionic multiple gestations. Ultrasound Obstet Gynecol 1996;8:16-22.
11.
Robie GF, Payne GG Jr, Morgan MA: Selective delivery of an acardiac, acephalic twin. N Engl J Med 1989;320:512-513.
12.
Rodeck C, Deans A, Jauniaux E: Thermocoagulation for the early treatment of pregnancy with an acardiac twin. N Engl J Med 1998;339:1293-1295.
13.
Ville Y, Hyett JA, Vandenbussche FP, Nicolaides KH: Endoscopic laser coagulation of umbilical cord vessels in twin reversed arterial perfusion sequence. Ultrasound Obstet Gynecol 1994;4:396-398.
14.
Quintero RA, Chmait RH, Murakoshi T, Pankrac Z, Swiatkowska M, Bornick PW, Allen MH: Surgical management of twin reversed arterial perfusion sequence. Am J Obstet Gynecol 2006;194:982-991.
15.
Onofrio BM: Cervical spinal cord and dentate delineation in percutaneous radiofrequency cordotomy at the level of the first to second cervical vertebrae. Surg Gynecol Obstet 1971;133:30-34.
16.
Huang SK, Bharati S, Graham AR, Lev M, Marcus FI, Odell RC: Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy - a new method of catheter ablation. J Am Coll Cardiol 1987;9:349-358.
17.
Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, Mayo-Smith WW: Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006;129:738-745.
18.
Nomura Y, Yamakado K, Tanaka H, Nagao K, Takeda K: Radiofrequency ablation for the treatment of hemorrhagic vaginal cancer. J Vasc Interv Radiol 2005;16:1557-1558.
19.
Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ: Radiofrequency ablation of liver tumors: a systematic review. Arch Surg 2006;141:181-90.
20.
Yamakado K, Nakatsuka A, Takaki H, Mori Y, Tonouchi H, Kusunoki M, Kida H, Takeda K: Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol 2005;16:1747-1751.
21.
Yamakado K, Nakatsuka A, Akeboshi M, Takaki H, Takeda K: Percutaneous radiofrequency ablation for the treatment of liver neoplasms in the caudate lobe left of the vena cava: electrode placement through the left lobe of the liver under CT-fluoroscopic guidance. Cardiovasc Intervent Radiol 2005;28:638-640.
22.
Yamakado K, Nakatsuka A, Kobayashi S, Akeboshi M, Takaki H, Kariya Z, Kinbara H, Arima K, Yanagawa M, Hori Y, Kato H, Sugimura Y, Takeda K: Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol 2006;29:389-394.
23.
Tsao K, Feldstein VA, Albanese CT, Sandberg PL, Lee H, Harrison MR, Farmer DL: Selective reduction of acardiac twin by radiofrequency ablation. Am J Obstet Gynecol 2002;187:635-640.
24.
Lee H, Wagner AJ, Sy E, Ball R, Feldstein VA, Goldstein RB, Farmer DL: Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence. Am J Obstet Gynecol 2007;196:459.e1-e4.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.